{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:22:29Z","timestamp":1794842549618,"version":"4.9.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82505439"],"award-info":[{"award-number":["82505439"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82374395"],"award-info":[{"award-number":["82374395"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"DOI":"10.1007\/s12011-026-05260-w","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:59:49Z","timestamp":1790639989000},"page":"9110-9121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Arsenic Trioxide in MRL\/lpr Mice: Disease-Context Support from Human Transcriptomic and DNA Methylation Datasets"],"prefix":"10.1007","volume":"204","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoYu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ChenXi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiaYing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XinYi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhiJun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"XiaoBing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"5260_CR1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Kostopoulou M, Alunno A et al (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78:736\u2013745. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215089","journal-title":"Ann Rheum Dis"},{"key":"5260_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nrrheum.2015.82","volume":"11","author":"JH Duarte","year":"2015","unstructured":"Duarte JH (2015) Connective tissue diseases: Large intergenic noncoding RNA linked to disease activity and organ damage in SLE. Nat Rev Rheumatol 11:384. https:\/\/doi.org\/10.1038\/nrrheum.2015.82","journal-title":"Nat Rev Rheumatol"},{"key":"5260_CR3","doi-asserted-by":"publisher","first-page":"347520","DOI":"10.1155\/2013\/347520","volume":"2013","author":"A Oglesby","year":"2013","unstructured":"Oglesby A, Shaul AJ, Pokora T et al (2013) Adverse event burden, resource use, and costs associated with immunosuppressant medications for the treatment of systemic lupus erythematosus: a systematic literature review. Int J Rheumatol 2013:347520. https:\/\/doi.org\/10.1155\/2013\/347520","journal-title":"Int J Rheumatol"},{"key":"5260_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13075-023-03143-2","volume":"25","author":"A Cauvet","year":"2023","unstructured":"Cauvet A, Decellas A, Guignabert C et al (2023) Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis. Arthritis Res therapy 25:167. https:\/\/doi.org\/10.1186\/s13075-023-03143-2","journal-title":"Arthritis Res therapy"},{"key":"5260_CR5","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1182\/blood-2006-04-020610","volume":"108","author":"P Bob\u00e9","year":"2006","unstructured":"Bob\u00e9 P, Bonardelle D, Benihoud K et al (2006) Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL\/lpr mice. Blood 108:3967\u20133975. https:\/\/doi.org\/10.1182\/blood-2006-04-020610","journal-title":"Blood"},{"key":"5260_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13075-021-02454-6","volume":"23","author":"M Hamidou","year":"2021","unstructured":"Hamidou M, N\u00e9el A, Poupon J et al (2021) Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic). Arthritis Res therapy 23:70. https:\/\/doi.org\/10.1186\/s13075-021-02454-6","journal-title":"Arthritis Res therapy"},{"key":"5260_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.intimp.2019.05.001","volume":"73","author":"C Li","year":"2019","unstructured":"Li C, Zhang J, Wang W et al (2019) Arsenic trioxide improves Treg and Th17 balance by modulating STAT3 in treatment-na\u00efve rheumatoid arthritis patients. Int Immunopharmacol 73:539\u2013551. https:\/\/doi.org\/10.1016\/j.intimp.2019.05.001","journal-title":"Int Immunopharmacol"},{"key":"5260_CR8","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","volume":"9","author":"NPD Liau","year":"2018","unstructured":"Liau NPD, Laktyushin A, Lucet IS et al (2018) The molecular basis of JAK\/STAT inhibition by SOCS1. Nat Commun 9:1558. https:\/\/doi.org\/10.1038\/s41467-018-04013-1","journal-title":"Nat Commun"},{"key":"5260_CR9","doi-asserted-by":"publisher","first-page":"1795760","DOI":"10.3389\/fimmu.2026.1795760","volume":"17","author":"Y Liu","year":"2026","unstructured":"Liu Y, Xiang L, Cheng RJ et al (2026) Advances in understanding the Th17\/Treg balance in systemic lupus erythematosus: implications for treatment and management. Front Immunol 17:1795760. https:\/\/doi.org\/10.3389\/fimmu.2026.1795760","journal-title":"Front Immunol"},{"key":"5260_CR10","doi-asserted-by":"publisher","first-page":"1425847","DOI":"10.3389\/fimmu.2024.1425847","volume":"15","author":"J Huang","year":"2024","unstructured":"Huang J, Li X, Zhu Q et al (2024) Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis. Front Immunol 15:1425847. https:\/\/doi.org\/10.3389\/fimmu.2024.1425847","journal-title":"Front Immunol"},{"key":"5260_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fimmu.2015.00183","volume":"6","author":"CM Ahmed","year":"2015","unstructured":"Ahmed CM, Larkin J 3rd, Johnson HM (2015) SOCS1 mimetics and antagonists: A complementary approach to positive and negative regulation of immune function. Front Immunol 6:183. https:\/\/doi.org\/10.3389\/fimmu.2015.00183","journal-title":"Front Immunol"},{"key":"5260_CR12","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.4049\/jimmunol.180.6.3746","volume":"180","author":"K Tanaka","year":"2008","unstructured":"Tanaka K, Ichiyama K, Hashimoto M et al (2008) Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. J Immunol (Baltimore Md: 1950) 180:3746\u20133756. https:\/\/doi.org\/10.4049\/jimmunol.180.6.3746","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"5260_CR13","doi-asserted-by":"publisher","first-page":"113013","DOI":"10.1016\/j.intimp.2024.113013","volume":"141","author":"J Yu","year":"2024","unstructured":"Yu J, Mei J, Zuo D et al (2024) Inflammatory factor-mediated miR-155\/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus. Int Immunopharmacol 141:113013. https:\/\/doi.org\/10.1016\/j.intimp.2024.113013","journal-title":"Int Immunopharmacol"},{"key":"5260_CR14","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.4049\/jimmunol.1101228","volume":"187","author":"LD Lu","year":"2011","unstructured":"Lu LD, Stump KL, Wallace NH et al (2011) Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2. Journal of immunology (Baltimore, Md: 1950) 187:3840-53. https:\/\/doi.org\/10.4049\/jimmunol.1101228","journal-title":"Journal of immunology"},{"key":"5260_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaut.2013.01.005","volume":"41","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Zhao M, Sawalha AH et al (2013) Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. J Autoimmun 41:92\u201399. https:\/\/doi.org\/10.1016\/j.jaut.2013.01.005","journal-title":"J Autoimmun"},{"key":"5260_CR16","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/art.38427","volume":"66","author":"Y Li","year":"2014","unstructured":"Li Y, Gorelik G, Strickland FM et al (2014) Oxidative stress, T cell DNA methylation, and lupus. Arthritis Rheumatol (Hoboken NJ) 66:1574\u20131582. https:\/\/doi.org\/10.1002\/art.38427","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"5260_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrrheum.2010.60","volume":"6","author":"JC Crisp\u00edn","year":"2010","unstructured":"Crisp\u00edn JC, Kyttaris VC, Terhorst C et al (2010) T cells as therapeutic targets in SLE. Nat Rev Rheumatol 6:317\u2013325. https:\/\/doi.org\/10.1038\/nrrheum.2010.60","journal-title":"Nat Rev Rheumatol"},{"key":"5260_CR18","doi-asserted-by":"publisher","first-page":"e35957","DOI":"10.1371\/journal.pone.0035957","volume":"7","author":"J Du","year":"2012","unstructured":"Du J, Zhou N, Liu H et al (2012) Arsenic induces functional re-expression of estrogen receptor \u03b1 by demethylation of DNA in estrogen receptor-negative human breast cancer. PLoS ONE 7:e35957. https:\/\/doi.org\/10.1371\/journal.pone.0035957","journal-title":"PLoS ONE"},{"key":"5260_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/toxsci\/kfm013","volume":"98","author":"JC Davey","year":"2007","unstructured":"Davey JC, Bodwell JE, Gosse JA et al (2007) Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci 98:75\u201386. https:\/\/doi.org\/10.1093\/toxsci\/kfm013","journal-title":"Toxicol Sci"},{"key":"5260_CR20","doi-asserted-by":"publisher","first-page":"e23497","DOI":"10.1096\/fj.202302362RR","volume":"38","author":"A Kor","year":"2024","unstructured":"Kor A, Sungu N, Karabulut \u015e et al (2024) Renal tubular estrogen \u00df receptors are expressed at high levels in small vessel vasculitis and are primarily localized in the distal tubule. FASEB journal: official publication Federation Am Soc Experimental Biology 38:e23497. https:\/\/doi.org\/10.1096\/fj.202302362RR","journal-title":"FASEB journal: official publication Federation Am Soc Experimental Biology"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05260-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-026-05260-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-026-05260-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:51:28Z","timestamp":1794840688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12011-026-05260-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":20,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5260"],"URL":"https:\/\/doi.org\/10.1007\/s12011-026-05260-w","relation":{},"ISSN":["1559-0720"],"issn-type":[{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"11 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}